Fingerprint
Dive into the research topics of 'Dose selection in seamless phase II/III clinical trials based on efficacy and safety'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Peter K. Kimani, Nigel Stallard, Jane L. Hutton
Research output: Contribution to journal › Article › peer-review